ValiRx plc (LON:VAL – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 0.57 ($0.01) and traded as low as GBX 0.50 ($0.01). ValiRx shares last traded at GBX 0.53 ($0.01), with a volume of 198,142 shares trading hands.
ValiRx Stock Performance
The stock has a market cap of £1.98 million, a PE ratio of -0.57 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.44. The firm has a 50 day moving average price of GBX 0.60 and a 200 day moving average price of GBX 0.57.
ValiRx (LON:VAL – Get Free Report) last announced its quarterly earnings results on Monday, September 29th. The company reported GBX (0.22) EPS for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. As a group, research analysts forecast that ValiRx plc will post -1.74 earnings per share for the current year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- How to Use the MarketBeat Stock Screener
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Stock Average Calculator
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
- P/E Ratio Calculation: How to Assess Stocks
- This Defense Stock Has a $57B Backlog and New AI Tailwinds
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
